Literature DB >> 35436032

Reply.

Hui Shi1, Jason S Knight2, Yogendra Kanthi3.   

Abstract

Entities:  

Year:  2022        PMID： 35436032      PMCID： PMC9082470          DOI： 10.1002/art.42141

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   15.483


× No keyword cloud information.
  10 in total

1.  Elevated von Willebrand Factor Antigen Is an Early Predictor of Mortality and Prolonged Length of Stay for Coronavirus Disease 2019 (COVID-19) Inpatients.

Authors:  Alexander H Cotter; Su-Jau T Yang; Hedyeh Shafi; Timothy M Cotter; Darryl Erik Palmer-Toy
Journal:  Arch Pathol Lab Med       Date:  2022-01-01       Impact factor: 5.534

2.  beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation.

Authors:  Janine J J Hulstein; Peter J Lenting; Bas de Laat; Ron H W M Derksen; Rob Fijnheer; Philip G de Groot
Journal:  Blood       Date:  2007-05-08       Impact factor: 22.113

3.  Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.

Authors:  George Goshua; Alexander B Pine; Matthew L Meizlish; C-Hong Chang; Hanming Zhang; Parveen Bahel; Audrey Baluha; Noffar Bar; Robert D Bona; Adrienne J Burns; Charles S Dela Cruz; Anne Dumont; Stephanie Halene; John Hwa; Jonathan Koff; Hope Menninger; Natalia Neparidze; Christina Price; Jonathan M Siner; Christopher Tormey; Henry M Rinder; Hyung J Chun; Alfred I Lee
Journal:  Lancet Haematol       Date:  2020-06-30       Impact factor: 18.959

4.  Platelets amplify endotheliopathy in COVID-19.

Authors:  Tessa J Barrett; MacIntosh Cornwell; Khrystyna Myndzar; Christina C Rolling; Yuhe Xia; Kamelia Drenkova; Antoine Biebuyck; Alexander T Fields; Michael Tawil; Elliot Luttrell-Williams; Eugene Yuriditsky; Grace Smith; Paolo Cotzia; Matthew D Neal; Lucy Z Kornblith; Stefania Pittaluga; Amy V Rapkiewicz; Hannah M Burgess; Ian Mohr; Kenneth A Stapleford; Deepak Voora; Kelly Ruggles; Judith Hochman; Jeffrey S Berger
Journal:  Sci Adv       Date:  2021-09-08       Impact factor: 14.136

Review 5.  Inflammation, Infection and Venous Thromboembolism.

Authors:  Meaghan E Colling; Benjamin E Tourdot; Yogendra Kanthi
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

6.  Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia.

Authors:  Francesco Taus; Gianluca Salvagno; Stefania Canè; Cristiano Fava; Fulvia Mazzaferri; Elena Carrara; Varvara Petrova; Roza Maria Barouni; Francesco Dima; Andrea Dalbeni; Simone Romano; Giovanni Poli; Marco Benati; Simone De Nitto; Giancarlo Mansueto; Manuela Iezzi; Evelina Tacconelli; Giuseppe Lippi; Vincenzo Bronte; Pietro Minuz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-14       Impact factor: 8.311

7.  The ADAMTS13-von Willebrand factor axis in COVID-19 patients.

Authors:  Ilaria Mancini; Luciano Baronciani; Andrea Artoni; Paola Colpani; Marina Biganzoli; Giovanna Cozzi; Cristina Novembrino; Massimo Boscolo Anzoletti; Valentina De Zan; Maria Teresa Pagliari; Roberta Gualtierotti; Stefano Aliberti; Mauro Panigada; Giacomo Grasselli; Francesco Blasi; Flora Peyvandi
Journal:  J Thromb Haemost       Date:  2020-12-18       Impact factor: 16.036

8.  Effects of anti-β2GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activity.

Authors:  Christopher J Ng; Keith R McCrae; Katrina Ashworth; Lucas J Sosa; Venkaiah Betapudi; Marilyn J Manco-Johnson; Alice Liu; Jing-Fei Dong; Dominic Chung; Tara C White-Adams; José A López; Jorge Di Paola
Journal:  Res Pract Thromb Haemost       Date:  2018-03-24

9.  Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes.

Authors:  Sara Fernández; Ana B Moreno-Castaño; Marta Palomo; Julia Martinez-Sanchez; Sergi Torramadé-Moix; Adrián Téllez; Helena Ventosa; Ferran Seguí; Ginés Escolar; Enric Carreras; Josep M Nicolás; Edward Richardson; David García-Bernal; Carmelo Carlo-Stella; José M Moraleda; Paul G Richardson; Maribel Díaz-Ricart; Pedro Castro
Journal:  Shock       Date:  2022-01-01       Impact factor: 3.533
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.